Literature DB >> 17221864

HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update.

Belinda Giardine1, Sjozef van Baal, Polynikis Kaimakis, Cathy Riemer, Webb Miller, Maria Samara, Panagoula Kollia, Nicholas P Anagnou, David H K Chui, Henri Wajcman, Ross C Hardison, George P Patrinos.   

Abstract

HbVar (http://globin.bx.psu.edu/hbvar) is a locus-specific database (LSDB) developed in 2001 by a multi-center academic effort to provide timely information on the genomic sequence changes leading to hemoglobin variants and all types of thalassemia and hemoglobinopathies. Database records include extensive phenotypic descriptions, biochemical and hematological effects, associated pathology, and ethnic occurrence, accompanied by mutation frequencies and references. In addition to the regular updates to entries, we report significant advances and updates, which can be useful not only for HbVar users but also for other LSDB development and curation in general. The query page provides more functionality but in a simpler, more user-friendly format and known single nucleotide polymorphisms in the human alpha- and beta-globin loci are provided automatically. Population-specific beta-thalassemia mutation frequencies for 31 population groups have been added and/or modified and the previously reported delta- and alpha-thalassemia mutation frequency data from 10 population groups have also been incorporated. In addition, an independent flat-file database, named XPRbase (http://www.goldenhelix.org/xprbase), has been developed and linked to the main HbVar web page to provide a succinct listing of 51 experimental protocols available for globin gene mutation screening. These updates significantly augment the database profile and quality of information provided, which should increase the already high impact of the HbVar database, while its combination with the UCSC powerful genome browser and the ITHANET web portal paves the way for drawing connections of clinical importance, that is from genome to function to phenotype. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17221864     DOI: 10.1002/humu.9479

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  54 in total

1.  An examination of the OMIM database for associating mutation to a consensus reference sequence.

Authors:  Zuofeng Li; Beili Ying; Xingnan Liu; Xiaoyan Zhang; Hong Yu
Journal:  Protein Cell       Date:  2012-04-04       Impact factor: 14.870

2.  Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes.

Authors:  S Sinha; M L Black; S Agarwal; R Colah; R Das; K Ryan; M Bellgard; A H Bittles
Journal:  Hugo J       Date:  2010-02-10

Review 3.  Population genetics of malaria resistance in humans.

Authors:  P W Hedrick
Journal:  Heredity (Edinb)       Date:  2011-03-23       Impact factor: 3.821

4.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

Review 5.  Hemoglobin research and the origins of molecular medicine.

Authors:  Alan N Schechter
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

Review 6.  An international registry of survivors with Hb Bart's hydrops fetalis syndrome.

Authors:  Duantida Songdej; Christian Babbs; Douglas R Higgs
Journal:  Blood       Date:  2017-01-05       Impact factor: 22.113

Review 7.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

8.  A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease.

Authors:  Damian Smedley; Max Schubach; Julius O B Jacobsen; Sebastian Köhler; Tomasz Zemojtel; Malte Spielmann; Marten Jäger; Harry Hochheiser; Nicole L Washington; Julie A McMurry; Melissa A Haendel; Christopher J Mungall; Suzanna E Lewis; Tudor Groza; Giorgio Valentini; Peter N Robinson
Journal:  Am J Hum Genet       Date:  2016-08-25       Impact factor: 11.025

9.  Familial polycythemia caused by a novel mutation in the beta globin gene: essential role of P50 in evaluation of familial polycythemia.

Authors:  Neeraj Agarwal; Mariluz P Mojica-Henshaw; Elizabeth D Simmons; Dottie Hussey; Ching N Ou; Josef T Prchal
Journal:  Int J Med Sci       Date:  2007-10-04       Impact factor: 3.738

Review 10.  Beta-thalassemia.

Authors:  Renzo Galanello; Raffaella Origa
Journal:  Orphanet J Rare Dis       Date:  2010-05-21       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.